Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity

European Journal of Echocardiography

Volumn 4, Issue 4, 2003, Pages 300-305

  Bountioukos, M ^a   Doorduijn, J K ^a   Roelandt, J R T C ^a   Vourvouri, E C ^a   Bax, J J ^a   Schinkel, A F L ^a   Kertai, M D ^a   Sonneveld, P ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anthracyclines; Dobutamine; Doppler; Drug toxicity; Echocardiography

Indexed keywords

ANTHRACYCLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOXORUBICIN; IDARUBICIN; INSULIN; MITOXANTRONE; NITRATE; ORAL ANTIDIABETIC AGENT; RAZOXANE;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL MOTION; HEMATOLOGIC MALIGNANCY; HUMAN; LOW DRUG DOSE; MALE; MITRAL VALVE; MYOCARDITIS; PERICARDITIS; PREDICTION; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SCORING SYSTEM; STRESS ECHOCARDIOGRAPHY; SYSTOLE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MYOCARDIAL CONTRACTION; RADIONUCLIDE VENTRICULOGRAPHY; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0345687962     PISSN: 15252167     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-2167(03)00017-9     Document Type: Article

References (25)

1. Menzin J, Lang K, Earle CC, Kerney D, Mallick R. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med 2002; 162: 1597-1603.
2. Alexander J, Dainiak N, Berger HJ et al. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 1979; 300: 278-283.
3. Larsen RL, Jackaki RI, Vetter VL, Meadows AT, Silber JH, Barger G. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 1992; 70: 73-77.
4. Bristow MR, Thompson PD, Martin RP, Mason JW, Billihgham ME, Hartison DC. Early anthracycline cardiotoxicity. Am J Med 1978; 65: 823-832.
5. Shuman RD, Ettinger DS, Abeloff MD, Livengood SV, Fortuin NJ. Comparative analysis of non-invasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Johns Hopkins Med J 1981; 149: 57-63.
6. Cohen M, Kronzon I, Lebowitz A. Reversible doxorubicin-induced congestive heart failure. Arch Intern Med 1982; 142: 1570-1571.
7. Von Hoff DD, Layard MW, Basa P et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91: 710-717.
8. Lipshultz SE, Lipsitz SR, Mone SM et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995; 332: 1738-1743.
9. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-1677.
10. Schwartz RG, Zaret B. Diagnosis and treatment of drug induced myocardial disease. In: Muggia FC, Speyer JL (Eds.), Cardiotoxicity of Anticancer Therapy, Johns Hopkins University Press, Baltimore, 1992, pp. 173-197.
11. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 2000; 22: 263-302.
12. Simbre VC II, Adams MJ, Deshpande SS, Duffy SA, Miller TL, Lipshultz SE. Cardiomyopathy caused by antineoplastic therapies. Curr Treat Options Cardiovasc Med 2001; 3: 493-505.
13. Hauser M, Wilson N. Anthracycline induced cardiomyopathy: successful treatment with angiotensin converting enzyme inhibitors. Eur J Pediatr 2000; 159: 389.
14. Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; 11: 97-104.
15. Elhendy A, van Domburg RT, Bax JJ et al. Optimal criteria for the diagnosis of coronary artery disease by dobutamine stress echocardiography. Am J Cardiol 1998; 82: 1339-1344.
16. Gottdiener JS, Mathisen DJ, Borer JS et al. Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide ventriculography. Ann Intern Med 1981; 94: 430-435.
17. Gottsauner-Wolf M, Schedlmayer-Duit J, Porenta G et al. Assessment of left ventricular function: comparison between radionuclide angiography and semiquantitative two-dimensional echocardiographic analysis. Eur J Nucl Med 1996; 23: 1613-1618.
18. Isner JM, Ferrans VJ, Cohen SR et al. Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients at necropsy. Am J Cardiol 1983; 51: 1167-1174.
19. De Wolf D, Suys B, Maurus R et al. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors. Pediatr Res 1996; 39: 504-512.
20. Tong J, Ganguly PK, Singal PK. Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am J Physiol 1991; 260: 909-915.
21. Leandro J, Dyck J, Poppe D et al. Cardiac dysfunction late after cardiotoxic therapy for childhood cancer. Am J Cardiol 1994; 74: 1152-1156.
22. Bae JH, Schwaiger M, Mandelkern M, Lin A, Schelbert HR. Doxorubicin cardiotoxicity: response of left ventricular ejection fraction to exercise and incidence of regional wall motion abnormalities. Int J Card Imaging 1988-89; 3: 193-201.
23. Cittadini A, Fazio S, D'Ascia C et al. Subclinical cardiotoxicity by doxorubicin: a pulsed Doppler echocardiographic study. Eur Heart J 1991; 12: 1000-1005.
24. Marchandise B, Schroeder E, Bosly A et al. Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J 1989; 118: 92-98.
25. Yamada E, Garcia M, Thomas JD, Marwick TH. Myocardial Doppler velocity imaging - a quantitative technique for interpretation of dobutamine echocardiography. Am J Cardiol 1998; 82: 806-880.